TwitterLinkedinSkypeRssEmail
+1.970.776.4355
BlueIron IP
  • About
  • IP-Backed Loans
  • Blog
  • All FAQs
    • Patent Loans
    • Patent Law FAQ
  • Contact
  • Schedule a Call

How is the regulatory review period for an animal drug determined?

By russ.krajec@blueironip.com | September 29, 2024

For animal drugs where the New Animal Drug Application (NADA) components were submitted to FDA in a phased review, the approval phase begins on the date of the submission of the administrative NADA. As stated in MPEP 2757: “To determine the regulatory review period for an animal drug where the New Animal Drug Application (NADA)…

Read More

Search

Categories

Recent Posts

  • Stolen Valor: How Sleazy Patent Attorneys Abuse Inventorship
  • Four Horsemen of the Investor Apocalypse
  • AI-Assisted Patent Search Tools Exacerbate Inventor Biases
  • Your Patent Attorney Is NOT Giving Business Advice
  • Contempt from Crowdfunded Equity
  • Entrepreneurs and Imposter Syndrome
  • AI Startups: Protect Everything EXCEPT the Patent
  • Blog
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Media Kit
BlueIron IP | 1635 Foxtrail Drive, Ste 321 | Loveland, Colorado 80538 | USA